Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model
Open Access
- 22 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (10) , 2523-2530
Abstract
Individual and group level factors associated with the probability of antimicrobial resistance of uropathogenic Escherichia coli were analysed in a multilevel model. Adult patients consulting with a suspected urinary tract infection (UTI) in 22 general practices over a 9 month period supplied a urine sample for laboratory analysis. Cases were patients with a UTI associated with a resistant E. coli. Previous antimicrobial exposure and other patient characteristics were recorded from the medical files. Six hundred and thirty-three patients with an E. coli UTI and a full record for all variables were included. Of the E. coli isolates, 36% were resistant to trimethoprim and 12% to ciprofloxacin. A multilevel logistic regression model was fitted. The odds that E. coli was resistant increased with increasing number of prescriptions over the previous year for trimethoprim from 1.4 (0.8–2.2) for one previous prescription to 4.7 (1.9–12.4) for two and 6.4 (2.0–25.4) for three or more. For ciprofloxacin the ORs were 2.7 (1.2–5.6) for one and 6.5 (2.9–14.8) for two or more. The probability that uropathogenic E. coli was resistant showed important variation between practices and a difference of 17% for trimethoprim and 33% for ciprofloxacin was observed for an imaginary patient moving from a practice with low to a practice with high probability. This difference could not be explained by practice prescribing or practice resistance levels. Previous antimicrobial use and the practice visited affect the risk that a patient with a UTI will be diagnosed with an E. coli resistant to this agent, which was particularly important for ciprofloxacin.Keywords
This publication has 29 references indexed in Scilit:
- Principles of multilevel analysis and its relevance to studies of antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2012
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysisBMJ, 2010
- A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practiceJournal of Antimicrobial Chemotherapy, 2010
- Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysisJournal of Antimicrobial Chemotherapy, 2008
- Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case–control studyJournal of Antimicrobial Chemotherapy, 2007
- Urinary tract infections in women: diagnosis and management in primary careBMJ, 2006
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005
- Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient dataBMJ, 2004
- Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factorsJournal of Antimicrobial Chemotherapy, 2001